Article
MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
PloS one - 1 Jan 2013
Ma Yong, Bian Jianmin, Cao Hongyong
Abstract excerpt
BACKGROUND: MDM2 is a major negative regulator of p53, and a single nucleotide polymorphism (SNP) in the MDM2 promoter region SNP309 has been demonstrated to be associated with an increased MDM2 expression and a significantly earlier age of onset of several tumors, including gastric cancer. Several studies were published to evaluate the association between SNP309 and gastric cancer risk. However, the results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
